Physician profile
Jonathan P Dean
NPI 1386931988
$3,742.77
in general payments reported to CMS, 2019-2025
21 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $832 · 2020: $2,060 · 2021: $310 · 2022: $92.43 · 2023: $96.06 · 2024: $156 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $447.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,058.64 | 2019-2020 | |
| Medical Device Business Services, INC. | $502.69 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $346.08 | 2019-2025 | Ofev |
| Davol INC. | $162.91 | 2020-2021 | |
| Edwards Lifesciences Corporation | $132.00 | 2019 | |
| Fujifilm Healthcare Americas Corporation | $104.16 | 2021 | |
| Tactile Systems Technology INC | $84.26 | 2025 | Flexitouch Plus, Nimbl |
| Smith+Nephew, INC. | $38.53 | 2022 | |
| Boston Scientific Corporation | $35.34 | 2024-2025 | Spyglass Discover |
| Kerecis Limited | $34.88 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Glaxosmithkline, LLC. | $34.10 | 2024 | Trelegy Ellipta |
| Stryker Corporation | $32.00 | 2023-2024 | 1788, Spy-Phi System, 1688 |
| Ethicon US, LLC | $29.08 | 2025 | Stratafix, Vistaseal, Ethicon |
| Acell, INC. | $24.79 | 2020 | |
| Novo Nordisk INC | $21.79 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $19.97 | 2023 | Myrisk |
| Kci USA, INC. | $19.69 | 2021 | |
| Baxter Healthcare | $18.10 | 2021 | |
| Olympus America INC. | $17.65 | 2024 | Olympus |
| Merck Sharp & Dohme LLC | $14.35 | 2019 | |
| Amgen INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.